The real-world effectiveness of intravenous brivaracetam as a second-line treatment in status epilepticus

CONCLUSION: The present study highlights the potential of BRV when used as an early add-on therapy in SE, further confirming its good safety profile.PMID:37839249 | DOI:10.1016/j.yebeh.2023.109464

Source: Epilepsy and Behaviour - October 15, 2023 Category: Neurology Authors: Chiara Martellino Angelina Lagan à Giorgia Atanasio Fabio Lamanna Silvia Attardo Simona Cascino Marcella De Luca Orazio Pardeo Giuseppa Giacobbe Giovanni Tripepi Roberta Roberti Francesca Granata Carmela Morace Emilio Russo Angelo Labate Source Type: research